Investors & Media
The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. To learn more about The Medicines Company and our work driving innovation in the cardiovascular disease space, visit our media toolkit here.
Press Releases
02 Sep 2019The Medicines Company Presents Results from ORION-11, First Phase 3 Trial of Inclisiran, Showing Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing01 Sep 2019The Medicines Company Statement on the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias26 Aug 2019The Medicines Company Announces Positive Topline Results from First Pivotal Phase 3 Trial of Inclisiran
View AllEvents & Presentations
Upcoming Events
There are no upcoming events at this time. Please check back.
Recent Events
Date
Event Details
31 Aug 2019